Top of page Skip navigation

Programme

 

08:30
Registration and Coffee

Chaired by Mary Clark M: Communications

09:15
Translational Research in the NHS, Professor Ian Bruce, Deputy Chair of the NIHR’s Translational Research Partnership (TRP) in Joint and Related Inflammatory Disease, Mark Samuels, Managing Director, Office for Clinical Research Infrastructure (NOCRI)
09:45
'Early clinical trials for cancer - a cross border collaboration' - Professor Steinar Aamdal, NECT (Nordic Network for Early Cancer Trials)
10:10
Astra Zeneca - Shaun Grady, VP Strategic Partnering and Business Development‘Partnering with AstraZeneca; Making the process more transparent’
10:30
Venture Capital investment in biotechnology
10.50
Coffee Break
Session 1
Maynard 1 Chaired by Richard Hayhurst MSL London

Pre-Clinical

Burdett Theatre chaired by Mark Swallow, Citigate Dewe Rogerson

Products in Clinical Trials 

Maynard 2 Chaired by Kevin Byrne, Clarkslegal

Platform/Diagnostics

11.30
Heptares Therapeutics
Critical Pharmaceuticals
InGell Labs BV
11.40
Malvern Therapeutics
Xention
Lein Applied Diagnostics
11.50
Almac Discovery
Silenseed
Pharmidex
12.00
BerGen Bio
Clavis Pharma
Kymab
12.10
Merus
Targovax
Bicycle Therapeutics
12.20
Epistem
Xenetic Biosciences
Q Chip
12.30
PhotoBiotics
Cyclacel
Epistem
12:40
Lunch
Session 2
Maynard 1 Chaired by Dr Kieran Rooney, Halo BioConsulting

Pre Clinical

Burdett Theatre Chaired by Vicki Connor, Dalriada Resources

Products in Clinical Trials

Maynard 2 Chaired by Richard Collins, Bio2Business

Platform & Diagnostics

14.00
Polytherics
Omnicyte
Hyglos
14.10
Physiomics
Oxford BioMedica
The Electrospinning Company
14.20
Allinky
Alloksys
Plasticell Therapeutics
14.30
Vaccibody
Convergence Pharmaceuticals
Progenitor Labs
14.40
APIM Therapeutics
Cell Medica
Octoplus
14.50
IR Pharma
Flamel Technologies
Crescent Diagnostics
15.00
Nextera
Diurnal
Pharming
15:10
Coffee
Session 3
Maynard 1


Burdett Theatre

Products in Clinical Trials

Maynard 2

Pre-Clin + Platform + Diagnostics

15.50
Proximagen
Protein Logic
16.00
Opsona Therapeutics
Aurelia Bioscience
16.10
Biotec Pharmacon
Genomic Vision
16.20
Virttu Biologics
BioMoti
16.30
APEIRON Biologics
Pathology Diagnostics
16.40
CureVac
16.50
17:00
Drinks and Networking